Cytosorbents Corp financial data

Symbol
CTSO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
305 College Road East, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
MedaSorb Technologies CORP (to 4/15/2010), GILDER ENTERPRISES INC (to 7/24/2006)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 173 % -40.5%
Quick Ratio 29.3 % +10.3%
Debt-to-equity 160 % +89.2%
Return On Equity -132 % -59%
Return On Assets -50.7 % -12.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.4M shares +22.7%
Common Stock, Shares, Outstanding 54.3M shares +23.8%
Entity Public Float 144M USD
Common Stock, Value, Issued 54.3K USD +22.9%
Weighted Average Number of Shares Outstanding, Basic 54.3M shares +23.4%
Weighted Average Number of Shares Outstanding, Diluted 54.3M shares +23.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 11.6M USD -20.3%
Operating Income (Loss) -25.1M USD +15.8%
Nonoperating Income (Expense) -1.24M USD -154%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -26.3M USD +4.34%
Income Tax Expense (Benefit) -1.09M USD -48.4%
Net Income (Loss) Attributable to Parent -25.5M USD +3.47%
Earnings Per Share, Basic -0.53 USD/shares +13.1%
Earnings Per Share, Diluted -0.53 USD/shares +13.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.46M USD -35.7%
Accounts Receivable, after Allowance for Credit Loss, Current 7.82M USD +11.4%
Inventory, Net 4.32M USD +111%
Assets, Current 22M USD -7.14%
Property, Plant and Equipment, Net 9.42M USD -10.3%
Operating Lease, Right-of-Use Asset 11.8M USD -4.41%
Other Assets, Noncurrent 3.77M USD -11.8%
Assets 53.4M USD +1.87%
Accounts Payable, Current 3.05M USD +7.44%
Accrued Liabilities, Current 498K USD -41.5%
Contract with Customer, Liability, Current 1.38M USD -8.96%
Liabilities, Current 10.3M USD -0.14%
Operating Lease, Liability, Noncurrent 12.7M USD -2.29%
Liabilities 36.7M USD +29.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.17M USD +63.7%
Retained Earnings (Accumulated Deficit) -293M USD -9.55%
Stockholders' Equity Attributable to Parent 16.7M USD -30.5%
Liabilities and Equity 53.4M USD +1.87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.83M USD -55.4%
Net Cash Provided by (Used in) Financing Activities -572K USD -184%
Net Cash Provided by (Used in) Investing Activities -127K USD +81.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 54.3M shares +22.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.52M USD -78.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.9M USD +0.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 199K USD +180%
Deferred Tax Assets, Valuation Allowance 45.3M USD +15.3%
Deferred Tax Assets, Gross 49M USD +13.7%
Operating Lease, Liability 13.1M USD +0.01%
Payments to Acquire Property, Plant, and Equipment 45.2K USD -91.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24.7M USD +13.9%
Lessee, Operating Lease, Liability, to be Paid 23.3M USD -5.23%
Property, Plant and Equipment, Gross 13.1M USD +3.58%
Operating Lease, Liability, Current 412K USD +260%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.72M USD +2.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.68M USD +30.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.2M USD -11.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.76M USD +2.37%
Deferred Tax Assets, Operating Loss Carryforwards 36.8M USD +16.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.8M USD +2.38%
Operating Lease, Payments 2.42M USD -8.12%
Additional Paid in Capital 308M USD +5.97%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.71M USD -3.27%
Share-based Payment Arrangement, Expense 3.49M USD +6.59%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%